Back to search

Orally administered pimonidazole to label hypoxic tumor cells.

Data up to Jan 2025

Published2002
Citations59
References20

Total Citations Per Year

Abstract

References (20)

Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects

2001 • 2,558 citations

Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole

1992 • 470 citations

Cells at Intermediate Oxygen Levels Can Be More Important Than the "Hypoxic Fraction" in Determining Tumor Response to Fractionated Radiotherapy

1997 • 340 citations

Comparisons among Pimonidazole Binding, Oxygen Electrode Measurements, and Radiation Response in C3H Mouse Tumors

1999 • 299 citations

Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver

1995 • 296 citations

Tumor tissue oxygenation as evaluated by computerized-po2-histography

1990 • 255 citations

Studies on a New Human Cell Line (SiHa) Derived from Carcinoma of Uterus. I. Its Establishment and Morphology

1970 • 203 citations

Proliferation and hypoxia in human squamous cell carcinoma of the cervix: First report of combined immunohistochemical assays

1997 • 201 citations

Detection of hypoxia in human squamous cell carcinoma by EF5 binding.

2000 • 188 citations

The OxyLite: a fibre-optic oxygen sensor.

1999 • 181 citations

Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours

1987 • 150 citations

Identification of nonproliferating but viable hypoxic tumor cells in vivo.

1998 • 139 citations

Cell selection from a murine tumour using the fluorescent probe Hoechst 33342

1985 • 120 citations

Changes in tumor hypoxia measured with a double hypoxic marker technique

2000 • 91 citations

The comet assay: A new method to examine heterogeneity associated with solid tumors

1998 • 82 citations

Use of a cell sorter for assays of cell clonogenicity.

1986 • 81 citations

Inducible Repair and the Two Forms of Tumour Hypoxia - Time for a Paradigm Shift

1999 • 74 citations

Intermittent blood flow in solid tumours--an under-appreciated source of 'drug resistance'.

2001 • 69 citations

Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia

2000 • 69 citations

Clinical Relevance of Intermittent Tumour Blood Flow

2001 • 53 citations

Cited By (0)

Loading...
Orally administered pimonidazole to label hypoxic tumor cells. (2002) – PubMed | Metascience Observatory Explorer